Skip to content

Ambispective study on the incidence and impact Of respiratory conditions in patients with Lung Cancer

An Ambispective Study on the Incidence and Impact of Non-Malignant Respiratory conditions in patients with Lung Cancer. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/086959
Enrollment
91
Registered
2025-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Poojary Aditya Praveen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age 18 years and above. Both male and female genders. Patients who have been admitted to either the inpatient or outpatient department of the hospital with a confirmed diagnosis of lung cancer, with or without co-morbidities

Exclusion criteria

Exclusion criteria: Patients below the age group of 17 years Patients who are unresponsive, unconscious, and comatose Patients who are not willing to participate in the study. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Incidence of non-malignant respiratory conditions eg pneumonia COPD exacerbations interstitial lung disease etc in lung cancer patients This could be expressed as a percentage or rate eg 20% of lung cancer patients developed non-malignant respiratory issues within a year Impact of these conditions on overall lung cancer disease progression and clinical management Example Increased need for treatment delays dose reductions hospitalizations etc Timepoint: 6 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactManish Kundar

Karavali college of Pharmacy

manishkundar6@gmail.com8105377059

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026